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Highlights
 Butyl and methyl parabens were tested for hepatotoxicity and dermal toxicity using HepG2 and 
HDFn cell lines.
 Butyl paraben showed significant concentration dependent cytotoxicity accompanied by ATP 
and GSH depletion in both cell lines.
 The HDFn cell line was more sensitive to the effects of butyl paraben when compared to HepG2.
 Butyl Paraben exposure led to slight perturbation in cell cycle of HepG2 cells.
 Methyl paraben did not show any significant cytotoxicity.
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7 Abstract
8 Parabens, esters of parahydroxybenzoic acid, are widely used in cosmetic, food and 
9 pharmaceutical industries mainly for their antibacterial and fungicidal properties. Methyl 
10 paraben has shown very low toxicity in a wide range of in vitro and animal tests. However, 
11 butyl paraben and derivatives, such as isobutyl parabens, are classified as allergens and have 
12 been shown to induce toxic effects. In the present study the effects of exposure to methyl or 
13 butyl paraben (5-1000μM) on cytotoxicity, oxidative stress, mitochondrial dysfunction and 
14 genotoxicity were measured in a hepatocarcinoma cell line (HepG2) and human dermal 
15 fibroblasts neonatal (HDFn). Butyl paraben caused a concentration dependent decrease (above 
16 400μM) in cell viability for both cell lines.  Toxicity of butyl paraben observed appeared to be 
17 mediated via ATP depletion as seen from luminescence assays. Depletion of glutathione was 
18 also observed for higher concentrations of butyl paraben, which may indicate the involvement 
19 of oxidative stress. Methyl paraben, however, did not show any significant decrease in cell 
20 viability, reduction in ATP or glutathione levels in HepG2 and HDFn cell lines at the 
21 concentrations tested. In vitro studies based on human cell lines can provide information in the 
22 early stages of multitier paraben toxicity studies and can be combined with in vivo and ex vivo 
23 studies to build more comprehensive, scientifically sound strategies for paraben safety testing.
24 The results obtained in this study could supplement existing in vivo toxicity data for defining 
25 more robust limits for human exposure.
26 Keywords: Butyl paraben, hepatotoxicity, dermal toxicity, HepG2, HDFn, oxidative stress, 
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28 Introduction
29 Parabens, esters of parahydroxybenzoic acid, are widely used in cosmetic, food and 
30 pharmaceutical industries mainly for their antibacterial and fungicidal properties. Stability over 
31 a wide pH range, low cost, broad spectrum activity and low toxicity were some of the reasons 
32 for the popularity of paraben as preservatives (Soni et al. 2005). p-Hydroxybenzoic acid is 
233 esterified at C-4 position and the paraben series mainly include methyl-, ethyl-,propyl-, butyl-, 
34 heptyl- and benzyl-paraben (Figure 1). Of these, methyl paraben has shown least toxicity in a 
35 wide range of in vitro and animal tests (acute and chronic studies) and is the most widely used 
36 paraben. Butyl paraben is routinely used as a preservative in some foods, cosmetics, drug 
37 formulations and baby products. Humans are also exposed to parabens from the environment 
38 (soil, air, biota and water) via inhalation, skin contact and ingestion (Ma et al. 2014). Even 
39 though parabens are rapidly hydrolysed by carboxylesterases, biomonitoring of butyl paraben 
40 based on their concentrations in urine (free/conjugated) showed presence of the parent 
41 compound in  50 – 70% (US), 80% (Denmark)  and 36% (Germany) of the test population 
42 (Calafat et al. 2010; Moos et al. 2014; Ye et al. 2006).
43 In vitro studies have shown that the effects of parabens   on a number of endpoints increases 
44 with an increase in the alkyl chain length (Błędzka et al. 2014; Tavares et al. 2009; Uramaru et 
45 al. 2014). The mode of action of parabens is thought to be the disruption of membrane transport 
46 and inhibition of mitochondrial function (Porceddu et al. 2012). Propyl paraben associated 
47 cytotoxicity was observed in rat primary hepatocytes as well as in in vitro studies using HepG2 
48 cells (Nakagawa and Moldéus 1998; Szeląg et al. 2016). Parabens are deemed to be mildly 
49 estrogenic and reproductive toxicity has been reported in several studies(Soni et al. 2005; 
50 Tavares et al. 2009). Several in vitro and in vivo studies have been conducted to ascertain the 
51 endocrine disrupting activity of parabens with special emphasis on the presence of methyl 
52 paraben being reported in breast cancer tissues (Darbre and Harvey 2008; Golden et al. 2005). 
53 utyl paraben and isobutyl paraben, are classified as allergens and have been shown to induce 
54 male reproductive disorders, male sexual developmental toxicity as well as multiple endocrine 
55 disrupting effects (Boberg et al. 2016; Guerra et al. 2017; Kang et al. 2002; Oishi 2002; 
56 Uramaru et al. 2014; Zhang et al. 2016).  Methyl paraben was shown to accelerate cellular 
57 aging in NHEK cells as well as  produce oxidative stress in HaCat cells upon exposure to 
58 ultraviolet light-B (Handa et al. 2006; Ishiwatari et al. 2007). 
59 As parabens are approved preservatives in cosmetics there has been considerable interest in the 
60 permeation and metabolism of parabens in skin. Multiple studies have been conducted in 
61 different in vitro, in vivo and ex vivo systems to assess these factors wherein the permeation 
62 ability as well as the permeation flux appeared to be related to the lipophilicity and molecular 
63 weight of parabens (Caon et al. 2010; Hatami et al. 2017; Moos et al. 2016; Pedersen et al. 
64 2007; Soni et al. 2005).
365 The concentration of butyl paraben considered safe, as stated by the European Union, is below 
66 0.19% (w/v) (SSC/1514/13). However, these limits are still subject to scientific scrutiny due to 
67 the following factors: lack of human studies; metabolic differences in rats and humans for 
68 parabens leading to difficulties in extrapolation; limited information on the systemic 
69 availability of free parabens and their metabolites as well as differential dermal absorption and 
70 metabolism in in vivo studies when compared to humans (Harville et al. 2007; Ulrike Bernauer 
71 et al. 2013). The permissible levels of methyl paraben and butyl paraben correspond to 26mM 
72 and 10mM respectively in solution (SSC/1514/13). Taking into consideration the increasing 
73 exposure of humans to butyl parabens via multiple routes, including the environment, the goal 
74 of this study was to measure the harmful effects of exposure to methyl or butyl paraben in an 
75 immortalised hepatocyte cell line and human neonatal dermal fibroblasts using an extended in 
76 vitro toxicity assay panel. The concentrations used in this study have been formulated based 
77 on a range below this (highest concentration is 1mM). In vitro studies on human cell lines can 
78 contribute to filling in the gap between animal studies and deriving limits for human exposure. 
79 The results obtained in this study could supplement existing in vivo toxicity data for defining 
80 more robust limits for human exposure.
81 Materials and Methods
82 Cell lines and reagents
83 HepG2  (ATCC® HB-8065™)  and HDFn (ATCC® PCS-201-010™) cells were obtained from 
84 Newcastle Central Biobank maintained on the ATCC cultures, Dulbecco's Modified Eagle 
85 Medium (DMEM, high glucose, with bicarbonates), Fetal Bovine Serum (FBS), Pencillin-
86 Streptomycin (10,000 units penicillin and 10 mg streptomycin/mL) , Phosphate Buffered Saline 
87 (PBS), Trypsin EDTA solution, MEM non-essential amino acids , L glutamine solutions 
88 200mM, Sodium Pyruvate Solution, Methyl paraben (CAS No: 99-76-3), butyl paraben (CAS 
89 No: 94-26-8), WST-1 (Cat. No: 05015944001), 2', 7’–dichlorofluorescin diacetate (DCFDA; 
90 CAS No: 4091-99-0), Dihydrorhodamine 123 (DHR123 CAS No: 109244-58-8), Hydrogen 
91 peroxide (CAS No: 7722-84-1) were purchased from Sigma Aldrich, UK. CellTiter-Glo® and 
92 GSH-Glo™ Reagent was purchased from Promega, UK and TMRE-Mitochondrial Membrane 
93 Potential Assay Kit was purchased from abcam, UK. The 96 well F bottom plates were 
94 purchased from GreinerBioOne.
495 Cell culture and maintenance
96 HepG2 and HDFn cells were grown as an adherent culture in complete growth media 
97 (Dulbecco’s Modified Eagle’s Media supplemented with 10% Fetal Bovine Serum, 1% 
98 Penicillin/Streptomycin, 1% Non-Essential amino Acids, 1% L-Glutamic acid and 1% Sodium 
99 Pyruvate) in T75 tissue culture flasks. The cells were subcultured 3 times a week using the 
100 following procedure: the spent media was removed and the cells were given a Phosphate 
101 Buffered Saline wash following which 1x diluted Trypsin was added to gently lift the cells. 
102 The cells were then re-suspended in 1:15 dilution in T75 tissue culture flasks.
103 Cell seeding and treatment
104 The HepG2 and HDFn cells were seeded at a density of 10000cells/well onto a Greiner 96-
105 well F bottom tissue culture plate. The cells were then exposed to concentrations ranging 
106 between 5-1000μM of the compounds: Methyl paraben or Butyl paraben and further incubated 
107 at 37°C 5% CO2 for 24 hourse(h).  Each assay contained a control, positive control and solvent 
108 control. The control were cells in media, solvent control contained the volume of solvent used 
109 for the highest concentrations used and the positive control was dependent on the assay and 
110 endpoint measured. 
111 WST-1 cell proliferation assay
112 Following the exposure of cells to the test compounds for 24 h, 10μl of WST-1 reagent was 
113 added per well and the plates were incubated for an additional 4 h. Endpoint measurements of 
114 absorbance were taken at 480nm and 600nm (background) on FLUOstar® Omega multimode 
115 microplate reader. Cell viability was expressed as a percentage of the control. Absorbance was 
116 also measured for solvent control. 
117 CellTiter-Glo® Luminescent Cell Viability Assay
118 Following the exposure of cells to the test compounds for 24 h, the plate and its contents were 
119 equilibrated at room temperature for approximately 30 minutes. Volume of Cell Titer-Glo® 
120 Reagent equal to the volume of cell culture medium present in each well (e.g., 100µl of reagent 
121 to 100µl of medium containing cells for a 96-well plate) was added. Contents were mixed for 
122 2 minutes on an orbital shaker to induce cell lysis. The plate was allowed to incubate at room 
123 temperature for 10 minutes to stabilize luminescent signal. Luminescence was recorded in 
124 FLUOStar Omega multiplate reader.
5125 GSH-Glo™ Glutathione Assay 
126 Following the exposure of cells, seeded in 96 well plates, to the test compounds for 24 h, culture 
127 media was removed from the plates. GSH-Glo™ reagent (100μl Luciferein-NT, 100μl of 
128 Glutathione S-Transferase and 10 ml of GSH-Glo™ reaction buffer) was added (100μl per well) 
129 and mixed briefly on a plate shaker followed by further incubation for 30 minutes at room 
130 temperature. Reconstituted Luciferin Detection reagent (100μl) was added to each well of the 
131 96 well plate. The contents of each plate were then mixed and incubated for 15 minutes at room 
132 temperature to stabilize luminescent signal. Luminescence was recorded in FLUOStar Omega 
133 multiplate reader.
134 Detection of Reactive oxygen species
135 Following the exposure of cells to the test compounds for 24 h, DCFDA was added to all wells 
136 at a final concentration of 10μM in well and the plates were incubated for an additional 30 
137 minutes. The media was removed from plates and the wells were washed once with PBS. The 
138 cells were resuspended in 200μl of PBS. Endpoint measurements of fluorescence were taken 
139 at 480nm (excitation maximum) and 520nm (emission maximum) on FLUOstar ® Omega 
140 multimode microplate reader. Reactive oxygen species (ROS) levels were expressed as a 
141 percentage of the control. Absorbance measurements were also read for solvent control as well 
142 as positive control (20μM-5mM final concentration of H2O2). A similar protocol was used for 
143 the Dihydrorhodamine 123 assay reagent.
144 Cell cycle Analysis
145 HepG2 cells were seeded in 24 well plates at a density of 2 x106 cells/ml. Following the 
146 exposure to the test compounds for 24h, the cells were gently lifted with 1X trypsin and cells 
147 washed once with Phosphate buffered saline (PBS). The cells were then fixed in 70% ethanol, 
148 added dropwise to avoid clumping. The samples were then washed twice in PBS and treated 
149 with 50μl of 100μg/ml ribonuclease followed by 50μl of 50μg/ml Propidium iodide (PI). The 
150 samples were then analysed by flow cytometry. Forward and side scatter was measured to 
151 identify various cell populations. Pulse processing was used to exclude cell doublets from 
152 analysis. PI has an emission maximum of 636 nm and it was measured in the FL2 channel 
153 (585/42bp filter) on Caliburs (pulse area vs pulse width). Typical voltage for PI in mammalian 
154 cells is around 400V on the Calibur. The data was analysed using FlowJo software where 
155 Gaussian curves were fit to obtain G1, S and G2/M % for each cell cycle distribution. The 
156 analysis was performed by the Flow Cytometry Core Facility, at Newcastle University.
6157 Mitochondrial Membrane Potential Assay
158 Following the exposure of cells to the test compounds for 24 h, the plate and its contents was 
159 equilibrated at room temperature for approximately 30 minutes. After removing the media, to 
160 eliminate background fluorescence, working solution of tetramethylrhodamine, ethyl ester 
161 (TMRE) solution prepared in media (final concentration 200nM) was added to cells. The plates 
162 were incubated for 30 minutes with subsequent media removal and replacement with 100µl of 
163 PBS. Endpoint measurements of fluorescence were taken at 549nm (excitation maximum) and 
164 575nm (emission maximum) on FLUOstar ® Omega multimode microplate reader. Final 
165 concentration of 20µM (carbonyl cyaninde 4-(trifluoromethoxy) phenylhydrazone) was used 
166 as a positive control.
167 Statistical analysis
168 Statistical analysis was carried out using Minitab 17 software. Statistically significant results 
169 were reported based on one way Analysis of variance (ANOVA) test followed by post hoc tests 
170 (Tukey’s/Fishers/Dunnett’s) (Ruxton and Beauchamp 2008) Graphpad Prism V.6.0 (Prism 
171 2014) was used for curve fitting and computing IC50 values.
172 Results
173 Paraben induced cytotoxicity
174 HepG2 and HDFn cells were treated with varying concentrations of butyl and methyl parabens. 
175 WST-1 is a tetrazolium salt that is converted by mitochondrial dehydrogenase enzymes into a 
176 water-soluble coloured formazan compound which is a measure of the metabolic activity of 
177 cells (Riss et al. 2016). Cell proliferation was expressed as a percentage of the control. A 
178 concentration dependent decrease in cell viability can be observed for HepG2 cells exposed to 
179 butyl paraben with a logIC50 of 2.81± 0.04 (IC50 643.7μM) (Figure 2a). For HDFn cells the 
180 logIC50 for butyl paraben was 2.70 ± 0.04 (IC50 502.5μM) (Figure 3a).  No statistically 
181 significant decrease in cell viability was observed in either of the cell lines for the entire 
182 concentration range of methyl paraben tested (Figure 2a, 3a).  A significant decrease in cell 
183 viability was measured for butyl paraben concentrations >300μM in both cell lines (Figure 2b, 
184 3b) (p<0.05, one-way ANOVA).
185 Paraben induced reduction in ATP levels
186 HepG2 and HDFn cells were treated with varying concentrations of butyl and methyl parabens. 
187 Cell Titer-Glo® Luminescent Cell Viability Assay allows for detection of metabolically active 
7188 cells through the quantification of Adenosine triphosphate (ATP). For HepG2 cells a 
189 concentration dependent decrease in luminescence was measured for butyl paraben with a 
190 logIC50 of  2.69 ± 0.03 (IC50 483.7μM) (Figure 2c). For HDFn a similar concentration 
191 dependent decrease was observed for butyl paraben with a logIC50 of 2.63 ± 0.03 (IC50 
192 425.2μM) (Figure 3c).  No reduction in ATP levels was measured in either of the cell lines for 
193 the entire concentration range of methyl paraben tested (Figure 2c, 3c). A significant reduction 
194 (p<0.05, one-way ANOVA) in ATP levels was measured for butyl paraben 
195 concentrations >300μM in both cell lines (Figure 2d, 3d).
196 Paraben induced reduction in glutathione levels
197 HepG2 and HDFn cells were treated with varying concentrations of butyl and methyl parabens.   
198 The luminescence generated is proportional to the glutathione levels present in cells. As in the 
199 previous tests, for HepG2 cells a concentration dependent decrease in GSH levels was observed 
200 for butyl paraben with a logIC50 of 2.65 ± 0.15 (IC50 448.9μM) (Figure 2e). For HDFn a 
201 similar concentration dependent decrease in GSH levels was observed for butyl paraben with 
202 a logIC50 of 2.64 ± 0.06 (IC50 438.1μM) (Figure 3e). Again, no reduction in GSH levels was 
203 observed in either of the cell lines for the concentration range of methyl paraben tested (Figure 
204 2e, 3e). Results were considered to be significant at p<0.05 based on one-way ANOVA test. A 
205 significant decrease in GSH levels can be observed for butyl paraben concentrations >300μM 
206 in both cell lines (Figure 2f, 3f)
207 Paraben induced time dependent decrease in ATP levels
208 Concentration and time dependent decrease of ATP was observed for butyl paraben in both 
209 cell lines (Figure 4). The percentage of ATP was measured at time intervals of 1, 4, 8, 12 and 
210 24 h and this was used to derive logIC50 and IC50 values as shown in Table 1. In HepG2 cells 
211 a 50% in ATP levels  and in HDFn cells approximately 97% decrease in ATP levels was  
212 observed based on the IC50 values calculated at 1h and 24h (Figure 4c, 4a).  Additionally the 
213 time dependent decrease in ATP levels was faster for HDFn when compared to HepG2. As 
214 seen in Figure 4a, ATP levels fall to about 50% of control at 1000 μM with HDFn after 1 h 
215 incubation whereas the decrease in HepG2 cells after 1 h is much lower (only to about 70%) 
216 as seen in Figure4c. Similarly, ATP levels fall to 30% of control at 4 h in HDFn cells compared 
217 to the 50% of control in HepG2 cells (Figure 4a and 4c). This indicates that the HDFn cell line 
218 is more sensitive to butyl paraben
8219  Methyl paraben did not show any decrease in ATP levels in response to concentration or time 
220 in either cell line. Indeed, ATP levels increased with methyl paraben concentrations with 
221 respect to the control for exposure durations of 4 h and 8 h (Figure 4b, 4d).
222 Table 1. Time dependent butyl paraben induced decrease in ATP levels expressed in term of logIC50, 
223 IC50 and standard error (SE) in HepG2 and HDFn cells.
HepG2 HDFnDuration of exposure 
(hrs) logIC50 SE IC50 (μM) logIC50 SE IC50 (μM)
1 2.99 ± 0.04 991.5 4.16 ± 0.26 14517
4 2.85 ± 0.02 708.6 3.02 ± 0.06 1044
8 2.95 ± 0.03 891.1 2.94 ± 0.02 870.2
12 2.81 ± 0.03 647.7 2.81 ± 0.02 649.9
24 2.63 ± 0.03 425.2 2.68 ± 0.02 484.1
224
225 Cell cycle analysis to assess genotoxicity of parabens
226 Propidium iodide, an intercalating DNA dye, is widely used for quantification of total DNA 
227 content by flow cytometry analysis (Krishan 1975). Cell cycle arrest compared to the control 
228 could be indicative of DNA damage and thus potential genotoxicity of compounds.  Compared 
229 to the control there was a small increase in HepG2 G1 cell population as well as a decrease in 
230 G2 and S for the highest concentration of Butyl paraben i.e. 200μM (Figure 5a). An increase 
231 in the cell population in G1 and G2 phases, as well as a concomitant decrease in the proportion 
232 of cells is S phase, was measured for methyl paraben when compared to the control cells for 
233 the highest concentration of methyl paraben i.e. 200μM (Figure 5b).  This cell cycle arrest in 
234 G1 phase was also measured with the positive control (50mM H2O2). For HDFn the highest 
235 proportion of cells was measured in S phase for the control whereas for 200μM butyl paraben 
236 the highest percentage of cells was measured in G2 phase. The highest percentage of cells 
237 exposed to all concentration of methyl paraben were observed in the G1 phase (Supplementary 
238 Figure S1).
239 Paraben induced Oxidative stress and mitochondrial dysfunction
240 HepG2 cells and HDFn cells were treated with varying concentrations of butyl or methyl 
241 paraben. DCFDA is a cell permeant fluorogenic dye that, upon deacetylation by cellular 
242 esterases, can be converted to a fluorescent compound in the presence of reactive oxygen 
243 species (ROS). The higher the fluorescence detected, the greater the amount of free radicals 
244 and thus higher oxidative stress (Liu et al. 2014). The positive control (hydrogen peroxide, 
9245 5mM at 24h) showed a high level of fluorescence compared to the control, however no 
246 concentration dependent increase in ROS was observed for either of the parabens 
247 (Supplementary Figure S2a, S2b).  Similar results were obtained using DHR123, a fluorogenic 
248 ROS indicator, for both HepG2 and HDFn cells exposed to varying concentrations of parabens 
249 (Possel et al. 1997). No concentration dependent increase in fluorescence signal was observed 
250 for either of the parabens but a high level was observed for the positive control (Supplementary 
251 Figure S3a, S3b). No changes in mitochondrial membrane potential were observed in HepG2 
252 cells for either of the parabens over the concentration range 0 to 1000 μM. (Supplementary 
253 Figure S3c).
254 Discussion
255 Parabens are widely used in pharmaceutical, cosmetic and food sector applications as 
256 preservatives. However, they have been shown to induce hepatotoxic and dermal toxic effects 
257 in several studies (Harville et al. 2007; Nakagawa and Moore 1999; Porceddu et al. 2012; Shah 
258 and Verma 2011). 
259 In our studies, butyl paraben was observed to cause a significant concentration dependent 
260 decrease in cell viability for HepG2 cells (IC50 643.7μM when incubated with cells for 24 h. 
261 Besides being in agreement with previous in vivo studies, we have also demonstrated 
262 cytotoxicity at concentrations many times lower than those reported in primary rat hepatocytes 
263 and mice (Nakagawa and Moldéus 1998; Shah and Verma 2011). The toxicity of butyl paraben 
264 observed appears to be accompanied by a significant dose dependent reduction in ATP (IC50 
265 483.7μM).  ATP is a sensitive marker for cell viability since as the cells lose membrane 
266 integrity, they fail to synthesize ATP and any remaining ATP in the cytoplasm is rapidly 
267 depleted by ATPases (Riss et al. 2016). This can also be reflective of mitochondrial dysfunction. 
268 This has been previously reported in HepG2 cells on exposure to propyl paraben as well as 
269 mice and rat primary hepatocytes upon exposure to butyl paraben (Nakagawa and Moldéus 
270 1998; Shah and Verma 2011; Szeląg et al. 2016). A significant dose dependent depletion of 
271 glutathione (GSH) levels was also observed for higher concentrations (IC50 448.9μM) of butyl 
272 paraben which may indicate an oxidative stress mechanism via GSH depletion. Dose dependent 
273 oxidative stress mediated hepatotoxicity has been observed in in vivo studies upon oral 
274 exposure to butyl paraben where significant dose dependent increase in lipid peroxidation (a 
275 consequence of oxidative stress) and decrease in glutathione levels were observed for higher 
276 concentrations (1000mM) (Shah and Verma 2011). 
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277 The decrease in ATP content of cells in response to butyl paraben was found to be time-
278 sensitive as well as concentration dependent.  A significant time and dose dependent decrease 
279 in ATP was also observed in HepG2 cells with 50% decrease in IC50 values based on ATP 
280 levels over a 24 h period. Butyl paraben was observed to cause a significant dose dependent 
281 cytotoxicity (IC50 502.5M) in HDFn cells which was accompanied by a corresponding 
282 significant dose dependent decrease in ATP levels (IC50 425.2μM) as well as GSH levels 
283 (IC50 438.1μM). A significant time and dose dependent decrease in ATP was also observed 
284 for HDFn cells with 97% decrease in cell viability over a 24 hr period.  At shorter exposure 
285 times, HDFn cells appeared to be more sensitive to butyl paraben than HepG2 cells.  After 1 h 
286 exposure, HDFn cells showed almost complete depletion of cellular ATP compared to controls, 
287 whilst HepG2 cells showed only a 50% reduction in ATP content.  This may be clinically 
288 significant, as liver cells are more likely to be exposed to the metabolite than the parent 
289 compound (either as a result of hydrolysis during absorption in the GI tract, in the plasma or 
290 by hepatic metabolism, whilst fibroblasts are more likely to be exposed to the parent compound.  
291 Cutaneous tissues are well understood to possess lower activities of hydrolytic enzymes than 
292 hepatic tissues.   
293 Methyl paraben did not show any significant decrease in cell viability, reduction in ATP or 
294 glutathione levels in HepG2 and HDFn cell lines at the concentrations tested. Cell proliferation 
295 was observed for higher concentration of methyl paraben in both cell lines. IC50 values could 
296 not be derived for methyl paraben as there was no apparent concentration dependent toxicity 
297 at the concentrations tested. Low concentrations of methyl paraben (200μM) showed 
298 accelerated cell aging in skin keratinocytes, however the incubation time was 32 days 
299 (Ishiwatari et al. 2007). 
300 There appeared to be no ROS mediated effect of either methyl or butyl paraben on cell viability 
301 as demonstrated by the DCFDA assay and DHR123 assay, a finding supported by research in 
302 previous studies (Soni et al. 2005). This could be due to the inability of these fluorescent probes 
303 to detect more transient and localised ROS production occurring in living cells (Dikalov and 
304 Harrison 2014; Forkink et al. 2010).  Furthermore, they cannot interact directly with hydrogen 
305 peroxide (H2O2) which might also explain the lack of elevated fluorescence observed at high 
306 concentrations of H2O2 in the DCFDA and DHR123 assays (Supplementary Figure S3a and b) 
307 compared to the extent of GSH depletion for lower concentrations H2O2 (Figure 2f and 3f).  
308 Some previous studies have reported ROS production as well as mitochondrial damage in 
309 response to paraben exposure, although the concentration range tested was far higher in those 
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310 reports (Nakagawa and Moldéus 1998; Shah and Verma 2011) than those tested in the present 
311 study. The potential to induce hepatotoxicity in isolated mouse liver mitochondria via damage 
312 to mitochondrial respiration has been reported for parabens (Porceddu et al. 2012). Butyl 
313 paraben induced mitochondrial permeation transition-mediated mitochondrial swelling was 
314 reported in the presence of 50μM calcium ions in isolated rat hepatocytes at a concentration of 
315 250μM (Nakagawa and Moore 1999). In the present study the TMRE assay was not able to 
316 detect any changes in mitochondrial membrane permeability for the highest concentration of 
317 parabens tested. This could be due to a lack of ions required to facilitate detection of increased 
318 membrane permeation via increased ion influx.  
319 Cell cycle analysis using propidium iodide staining methods has been used to study cell cycle 
320 arrest at different phases to provide an indirect measure of genotoxicity (Esmaeelian et al. 2013; 
321 Krishan 1975). A dose dependent cell cycle arrest in the G1 phase and decrease in S phase was 
322 observed for HepG2 cells exposed to the highest non-cytotoxic concentration of butyl paraben 
323 (200μM). These results are comparable to a previous study which showed a significant dose 
324 dependent decrease in mitotic cells as well as cycle arrest in G1 phase observed in Vero cells 
325 exposed to 500μM propyl paraben (Martín et al. 2010). Chromosomal aberrations and an 
326 increase in polyploid cells were observed in an in vitro genotoxicity assays of butyl paraben at 
327 a dose of 308 μM (Ishidate Jr et al. 1978). Further analysis such as gene mutation in mammalian 
328 cells systems, γ-H2AX assay (test for DNA damage) as well as chromosomal aberrations tests 
329 would be required to provide clarity on the mechanism of potential genotoxicity(Ivashkevich 
330 et al. 2012; Knight et al. 2009).
331 Considering the two main routes for paraben exposure, oral and/or topical, two main aspects 
332 must be taken into consideration while interpreting and setting toxicity limits: hydrolysis and 
333 permeation, which is in turn influence by the alkyl chain length of parabens. Permeation of 
334 parabens into skin layers upon topical application has been demonstrated by different studies 
335 and this is influenced by the lipophilicity and molecular weight of parabens in different in vivo 
336 and ex vivo models (Caon et al. 2010; Pedersen et al. 2007).  Previous reports have shown that 
337 parabens with increased chain length exhibit increased potency (Prusakiewicz et al. 2007). 
338 Elimination rate via urine decreases with increasing length of alkyl chain as this increases the 
339 lipophilicity of paraben as reflected in previous studies (Moos et al. 2016). Butyl parabens have 
340 shown rapid biotransformation in terms of glucuronidation and hydrolysis when compared to 
341 methyl paraben in human liver microsomes and plasma respectively, further studies have to be 
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342 conducted to distinguish the effect of the butyl or methyl parabens from its primary metabolite 
343 which is p-hydroxybenzoic acid (Abbas et al. 2010). 
344 Human exposure to parabens has become extensive due to their presence in consumer products 
345 as well as via environmental routes. In conclusion our results have demonstrated the potential 
346 hepatotoxic and dermal toxic effect of butyl paraben which appears to be accompanied by ATP 
347 and GSH depletion reflective of mitochondrial dysfunction and oxidative stress respectively 
348 using HepG2 and HDFn as in vitro models. Our finding also indicates a time depended decrease 
349 in ATP levels which provides a useful basis for further toxicokinetic studies. An insight has 
350 also been provided into the potential cell cycle arresting tendency of butyl paraben. Due to a 
351 lack of data from human studies as well as difference in pharmacokinetic/pharmacodynamics 
352 behaviour of animal model studies when compared to humans, a scientifically sound 
353 conclusion cannot be reached by regulatory authorities on the safe usable limits of parabens. 
354 These in vitro studies could form the preliminary step at bridging the gap between in vivo data 
355 and extrapolation to set safe use limits in pharmaceutical, cosmetics and food products. 
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488 Figure legends
489 Fig 1: Chemical structures of methyl paraben(CSID:7176) butyl paraben(CSID:6916) and 4-
490 Hydroxybenzoic acid (CSID:132) (Source ChemSpider, Royal Society of Chemistry)
491 Fig 2: Results of the different in vitro tests performed on HepG2 cell after treatment with Butyl 
492 paraben and Methyl paraben for 24 h. Cell viability assay using WST-1 reagent (a) Dose 
493 response curve (b) concentration vs percentage of the control response. ATP reduction assay 
494 using CellTiter-Glo® (c) Dose response curve (d) concentration vs percentage of the control 
495 response. GSH reduction using GSH-Glo™ (e) Dose response curve (f) concentration vs 
496 percentage of the control response. All values are expressed as a percentage of the control and 
497 mean ± standard error of the mean (SEM) for n=3. Statistical differences were assessed with 
498 one way ANOVA. Dunnett’s post hoc test was used for multiple comparisons to control. ** 
499 indicates p<0.05, *** indicates p<0.001
500 Fig 3: Results of the different in vitro tests performed on HDFN cell after treatment with Butyl 
501 paraben and Methyl paraben. Cell viability assay using WST-1 reagent (a) Dose response curve 
502 (b) concentration vs percentage of control response. ATP reduction assay using CellTiter-Glo® 
503 (c) Dose response curve (d) concentration vs percentage of control response. GSH reduction 
504 using GSH-Glo™ (e) Dose response curve (f) concentration vs percentage of control response. 
505 All values are expressed as percentage of control and mean ± standard error of the mean (SEM) 
506 for n=3.  Statistical differences were assessed with one way ANOVA. Dunnett’s post hoc test 
507 was used for multiple comparisons to control. ** indicates p<0.05, *** indicates p<0.001
508 Fig 4: Dose response curves of the reduction in ATP levels measured over time after the 
509 exposure of cells to different concentrations of parabens for 1, 4, 8, 12 and 24 h using CellTiter-
510 Glo®. Dose response curves for HDFN after treatment with (a) Butyl Paraben (b) Methyl 
511 Paraben. Dose response curves for HepG2 after treatment with (c) Butyl Paraben (d) Methyl 
512 Paraben All values are expressed as percentage of control and mean ± standard error of the 
513 mean (SEM) for n=3
16
514 Fig 5: Graphical representation of cell cycle phase proportions following cell fixing, Propidium 
515 Iodide staining and analysis by flow cytometry for (a) HepG2 cells treated with butyl paraben 
516 (b) HepG2 cells treated with methyl paraben. All values are expressed as a percentage of the 
517 control and mean ± standard error of the mean (SEM) for n=3. Statistical differences were 
518 assessed with one way ANOVA. Dunnett’s post hoc test was used for multiple comparisons to 
519 control. ** indicates p<0.05.
520 Fig S1: Graphical representation of cell cycle phase proportions following cell fixing, 
521 Propidium Iodide staining and analysis by flow cytometry for (a) HDFn cells treated with butyl 
522 paraben (b) HDFn cells treated with methyl paraben.
523 Fig S2: Results of the DCFDA assay to measure ROS production in HepG2 cells after 
524 treatments with (a) butyl paraben and (b) methyl paraben, All values are expressed as 
525 percentage of control and mean ± standard error of the mean (SEM) for n=3.
526 Fig S3. Results of the DHR 123 assay to measure oxidative stress in (a) HepG2 and (b) HDFN 
527 cell lines after treatment with Butyl paraben and Methyl paraben. Results of the TMRE assay 
528 to measure mitochondrial membrane potential in (c) HepG2 cells after treatments with 
529 parabens, All values are expressed as percentage of control and mean ± standard error of the 
530 mean (SEM) for n=3. FCCP: Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone







